KR100882744B1 - 목단피 추출물을 함유하는 화장료 조성물의 제조방법 - Google Patents
목단피 추출물을 함유하는 화장료 조성물의 제조방법 Download PDFInfo
- Publication number
- KR100882744B1 KR100882744B1 KR1020080109485A KR20080109485A KR100882744B1 KR 100882744 B1 KR100882744 B1 KR 100882744B1 KR 1020080109485 A KR1020080109485 A KR 1020080109485A KR 20080109485 A KR20080109485 A KR 20080109485A KR 100882744 B1 KR100882744 B1 KR 100882744B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- skin
- bark
- cosmetic composition
- effect
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 94
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- 239000002537 cosmetic Substances 0.000 title claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 title claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 29
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 210000003491 skin Anatomy 0.000 claims description 47
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 42
- 239000002904 solvent Substances 0.000 claims description 26
- 238000000605 extraction Methods 0.000 claims description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 11
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 10
- 210000004207 dermis Anatomy 0.000 claims description 9
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims 1
- 150000002334 glycols Chemical class 0.000 claims 1
- 229920000642 polymer Polymers 0.000 abstract description 22
- 230000037303 wrinkles Effects 0.000 abstract description 22
- 230000003078 antioxidant effect Effects 0.000 abstract description 18
- 102000008186 Collagen Human genes 0.000 abstract description 17
- 108010035532 Collagen Proteins 0.000 abstract description 17
- 229920001436 collagen Polymers 0.000 abstract description 17
- 102000029816 Collagenase Human genes 0.000 abstract description 14
- 108060005980 Collagenase Proteins 0.000 abstract description 14
- 229960002424 collagenase Drugs 0.000 abstract description 14
- 230000015572 biosynthetic process Effects 0.000 abstract description 11
- 238000003786 synthesis reaction Methods 0.000 abstract description 11
- 230000032683 aging Effects 0.000 abstract description 9
- 230000003712 anti-aging effect Effects 0.000 abstract description 9
- 230000010261 cell growth Effects 0.000 abstract description 9
- 230000002401 inhibitory effect Effects 0.000 abstract description 9
- 239000004480 active ingredient Substances 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract description 7
- 229910052698 phosphorus Inorganic materials 0.000 abstract description 5
- 239000011574 phosphorus Substances 0.000 abstract description 5
- 240000005001 Paeonia suffruticosa Species 0.000 abstract description 3
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 description 31
- 235000019441 ethanol Nutrition 0.000 description 25
- 206010040954 Skin wrinkling Diseases 0.000 description 21
- -1 alkyl peroxide Chemical class 0.000 description 19
- 230000000694 effects Effects 0.000 description 19
- 238000009472 formulation Methods 0.000 description 18
- 238000012360 testing method Methods 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000006071 cream Substances 0.000 description 10
- 230000006872 improvement Effects 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000002421 anti-septic effect Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 230000009759 skin aging Effects 0.000 description 8
- 230000037394 skin elasticity Effects 0.000 description 8
- 238000007796 conventional method Methods 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000002023 wood Substances 0.000 description 7
- 239000006210 lotion Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- 241000736199 Paeonia Species 0.000 description 5
- 235000006484 Paeonia officinalis Nutrition 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000004663 cell proliferation Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 231100000430 skin reaction Toxicity 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 102000016942 Elastin Human genes 0.000 description 4
- 108010014258 Elastin Proteins 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 4
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 4
- 229940113124 polysorbate 60 Drugs 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000037319 collagen production Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000007933 dermal patch Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- IVSPJKRLTWBHHN-UHFFFAOYSA-N 1-sulfanyloxybutane Chemical compound CCCCOS IVSPJKRLTWBHHN-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- IRLNKOAURQPXIQ-WWWUCTDISA-N Apiopaeonoside Natural products O=C(C)c1c(O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO[C@H]3[C@H](O)[C@@](O)(CO)CO3)O2)cc(OC)cc1 IRLNKOAURQPXIQ-WWWUCTDISA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- IDZZECHGWAZTIB-NYBIBFQCSA-N Paeonolide Chemical compound COC1=CC=C(C(C)=O)C(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H](O)[C@@H](O)CO3)O)O2)O)=C1 IDZZECHGWAZTIB-NYBIBFQCSA-N 0.000 description 1
- IDZZECHGWAZTIB-WPQJODJHSA-N Paeonolide Natural products O=C(C)c1c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]3[C@@H](O)[C@H](O)[C@@H](O)CO3)O2)cc(OC)cc1 IDZZECHGWAZTIB-WPQJODJHSA-N 0.000 description 1
- AVIUTYMRHHBXPB-UXXRCYHCSA-N Paeonoside Natural products COC1=CC=C(C(C)=O)C(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1 AVIUTYMRHHBXPB-UXXRCYHCSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- GPNXNVXCMUMHTQ-ZZMUEVMSSA-J [Mo+4].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] Chemical compound [Mo+4].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] GPNXNVXCMUMHTQ-ZZMUEVMSSA-J 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- IDZZECHGWAZTIB-UHFFFAOYSA-N affinoside Natural products COC1=CC=C(C(C)=O)C(OC2C(C(O)C(O)C(COC3C(C(O)C(O)CO3)O)O2)O)=C1 IDZZECHGWAZTIB-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 229940079894 benzophenone-9 Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 102000036444 extracellular matrix enzymes Human genes 0.000 description 1
- 108091007167 extracellular matrix enzymes Proteins 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- AVIUTYMRHHBXPB-UHFFFAOYSA-N glucopaeonol Natural products COC1=CC=C(C(C)=O)C(OC2C(C(O)C(O)C(CO)O2)O)=C1 AVIUTYMRHHBXPB-UHFFFAOYSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910052811 halogen oxide Inorganic materials 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- XFFQVRFGLSBFON-DEFKTLOSSA-N kaempferol 3,7-di-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=C(C=3C=CC(O)=CC=3)OC2=C1 XFFQVRFGLSBFON-DEFKTLOSSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229920001523 phosphate polymer Polymers 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Abstract
Description
제조예 | 추출용매 | 건조 중량 (g) |
1 | 물 | 28.6 |
2 | 메탄올 | 27.1 |
3 | 에탄올 | 29.4 |
4 | 프로판올 | 25.6 |
5 | 부탄올 | 27.6 |
6 | 아세톤 | 22.1 |
7 | 에틸아세테이트 | 23.4 |
8 | 클로로포름 | 8.7 |
9 | 글리세린 | 26.4 |
10 | 부틸렌글리콜 | 28.6 |
11 | 프로필렌글리콜 | 26.7 |
12 | 디클로로메탄 | 9.1 |
13 | 헥산 | 16.4 |
14 | 벤젠 | 14.7 |
15 | 물:메탄올:프로필렌글리콜 (2:1:1) | 28.3 |
16 | 물:에탄올:프로필렌글리콜 (2:1:1) | 27.5 |
17 | 물:에탄올:부틸렌글리콜 (2:1:1) | 28.1 |
제조예 | 인중합체 함량 (ng/ml) |
1 | 7.5 |
2 | 7.1 |
3 | 7.6 |
4 | 7.9 |
5 | 7.4 |
6 | 4.4 |
7 | 4.4 |
8 | 1.7 |
9 | 6.1 |
10 | 7.2 |
11 | 7.4 |
12 | 1.3 |
13 | 1.2 |
14 | 2.0 |
15 | 11.6 |
16 | 17.4 |
17 | 11.4 |
제조예 | 세포 증식능 (%) | ||
처리농도 (0.005%) | 처리농도 (0.05%) | 처리농도 (0.5%) | |
대조군 | 100.0 | 100.0 | 100.0 |
1 | 107.4 | 157.8 | 244.0 |
2 | 109.4 | 159.7 | 240.6 |
3 | 107.1 | 157.6 | 240.4 |
4 | 109.8 | 157.2 | 241.5 |
5 | 108.9 | 158.4 | 240.4 |
6 | 101.7 | 120.7 | 147.5 |
7 | 108.5 | 117.5 | 130.4 |
8 | 100.8 | 115.4 | 129.8 |
9 | 105.6 | 140.8 | 198.7 |
10 | 108.5 | 140.6 | 200.8 |
11 | 109.1 | 150.6 | 210.5 |
12 | 104.3 | 123.1 | 140.5 |
13 | 102.1 | 126.7 | 131.1 |
14 | 101.4 | 110.8 | 123.7 |
15 | 118.4 | 171.4 | 297.6 |
16 | 120.9 | 199.4 | 324.1 |
17 | 119.5 | 170.0 | 297.0 |
제조예 | 항산화 효과 (%) |
1 | 39.4 |
2 | 37.2 |
3 | 39.9 |
4 | 41.8 |
5 | 38.5 |
6 | 26.7 |
7 | 26.4 |
8 | 8.2 |
9 | 30.1 |
10 | 37.5 |
11 | 38.6 |
12 | 4.1 |
13 | 3.6 |
14 | 8.5 |
15 | 73.0 |
16 | 89.4 |
17 | 72.2 |
제조예 | 콜라겐 생성능 (%) |
대조군 | 100.0 |
1 | 139.4 |
2 | 137.1 |
3 | 140.5 |
4 | 148.3 |
5 | 138.6 |
6 | 124.3 |
7 | 124.6 |
8 | 108.4 |
9 | 131.3 |
10 | 137.9 |
11 | 138.8 |
12 | 106.5 |
13 | 106.1 |
14 | 109.6 |
15 | 181.6 |
16 | 204.9 |
17 | 180.8 |
제조예 | 콜라게나아제활성 억제율 (%) |
대조군 | 0.0 |
1 | 65.7 |
2 | 61.4 |
3 | 66.8 |
4 | 67.4 |
5 | 65.1 |
6 | 21.2 |
7 | 21.3 |
8 | 11.8 |
9 | 53.7 |
10 | 61.8 |
11 | 65.1 |
12 | 9.8 |
13 | 9.4 |
14 | 16.8 |
15 | 83.1 |
16 | 96.7 |
17 | 82.0 |
성분 | 실시예 1 (중량%) | 실시예 2 (중량%) | 비교예 1 (중량%) |
목단피 추출물(제조예 13) | 5.0 | - | - |
목단피 추출물(제조예 16) | - | 5.0 | - |
글리세린 | 5.0 | 5.0 | 5.0 |
락틴산 | - | - | 5.0 |
유동파라핀 | 10.0 | 10.0 | 10.0 |
폴리솔베이트60 | 2.0 | 2.0 | 2.0 |
솔비탄세스퀴롤올레이트 | 1.0 | 1.0 | 1.0 |
스쿠알란 | 5.0 | 5.0 | 5.0 |
밀납 | 10. | 10.0 | 10. |
트리에탄올아민 | 0.5 | 0.5 | 0.5 |
프로필렌 글리콜 | 1.0 | 1.0 | 1.0 |
카르복실비닐폴리머 | 1.5 | 1.5 | 1.5 |
향 | 미량 | 미량 | 미량 |
방부제 | 미량 | 미량 | 미량 |
정제수 | 잔량 | 잔량 | 잔량 |
계 | 100 | 100 | 100 |
기 호 | 점수 | 평가 기준 |
- | 0 | 무반응 |
± | 0.5 | 희미한 또는 가벼운 홍반 |
+ | 1 | 경계가 뚜렷하나 약한 홍반, 부종 및 구진 |
++ | 2 | 뚜렷한 홍반, 구진 및 소수포 |
+++ | 3 | 심한 홍반 및 대수포, 가피형성 |
시험물질 | 1 시간 후 | 24 시간 후 | 반응도 (%) (n=20) | ||||
± | + | ++ | ± | + | ++ | ||
실시예 1 | - | - | - | - | - | - | 0.00 |
실시예 2 | - | - | - | - | - | - | 0.00 |
비교예 1 | 13 | 3 | - | 5 | 3 | - | 12.50 |
0 day | 실시예 1 | 실시예 2 | 비교예 1 |
R1 | 3.007 | 3.012 | 3.010 |
R2 | 2.990 | 2.995 | 2.993 |
R3 | 1.142 | 1.134 | 1.137 |
R4 | 0.251 | 0.249 | 0.247 |
R5 | 0.375 | 0.369 | 0.368 |
60 day | 실시예 1 | 실시예 2 | 비교예 1 |
R1 | 2.895 | 2.820 | 3.007 |
R2 | 2.480 | 2.108 | 2.991 |
R3 | 1.002 | 0.092 | 1.131 |
R4 | 0.228 | 0.115 | 0.246 |
R5 | 0.334 | 0.292 | 0.363 |
비 고 | 피부탄력 개선도 (%) |
실시예 1 | 38.4 |
실시예 2 | 77.1 |
비교예 1 | 5.7 |
원료명 | 함량 (중량%) |
제조예 16 | 5.0 |
1,3-부틸렌글리콜 | 5.2 |
올레일알코올 | 1.5 |
에탄올 | 3.2 |
폴리솔베이트 20 | 3.2 |
벤조페논-9 | 2.0 |
카르복실비닐폴리머 | 1.0 |
글리세린 | 3.5 |
향 | 미량 |
방부제 | 미량 |
정제수 | 잔량 |
계 | 100 |
원료명 | 함량 (중량%) |
제조예 16 | 5.0 |
세토스테아릴 알코올 | 1.0 |
글리세릴모노스테아레이트 | 0.8 |
소르비탄모노스테아레이트 | 0.3 |
폴리솔베이트 60 | 1.0 |
미네랄오일 | 5.0 |
사이크로메치콘 | 3.0 |
디메치콘 | 0.5 |
알란토인 | 0.1 |
글리세린 | 5.0 |
알코올 | 2 |
프로필렌글리콜 | 3.0 |
향 | 미량 |
방부제 | 미량 |
정제수 | 잔량 |
계 | 100 |
원료명 | 함량 (중량%) |
제조예 16 | 5.0 |
1,3-부틸렌글리콜 | 4.0 |
글리세린 | 3.0 |
알란토인 | 0.5 |
판테놀 | 0.1 |
EDTA-2Na | 0.01 |
에탄올 | 5.0 |
트리에탄올아민 | 1.5 |
스쿠알란 | 2.0 |
밀납 | 2.5 |
폴리솔베이트60 | 3.5 |
카르복실비닐폴리머 | 1.0 |
솔비탄세스퀴올레이트 | 2.5 |
향 | 미량 |
방부제 | 미량 |
정제수 | 잔량 |
계 | 100 |
원료명 | 함량 (중량%) |
제조예 16 | 5.0 |
에틸알코올 | 3.0 |
EDTA-2Na | 0.05 |
프로필렌 글리콜 | 5.0 |
글리셀린 | 4.5 |
카보폴 | 1.5 |
폴리옥사이드 | 0.2 |
방부제 | 미량 |
향 | 미량 |
정제수 | 잔량 |
계 | 100 |
원료명 | 함량 (중량%) |
제조예 16 | 5.0 |
글리세린 | 4.0 |
바세린 | 3.5 |
트리에탄올아민 | 0.5 |
유동파라핀 | 24.0 |
스쿠알란 | 3.0 |
밀납 | 2.1 |
토코페릴아세테이트 | 0.1 |
폴리솔베이트 60 | 2.4 |
카르복실비닐폴리머 | 1.0 |
솔비탄세스퀴올레이트 | 2.3 |
향 | 미량 |
방부제 | 미량 |
정제수 | 잔량 |
계 | 100 |
원료명 | 함량 (중량%) |
제조예 16 | 5.0 |
알킬황산염 (30%) | 25.0 |
알킬에텔황산염 (30%) | 20.0 |
알킬아미도베타인 (30%) | 5.0 |
프로필렌글리콜 | 3.0 |
라우라미드이에이 | 4.0 |
EDTA-2Na | 0.1 |
폴리쿼터늄-10 | 0.05 |
NaCl | 0.1 |
구연산 | 2.4 |
향 | 미량 |
방부제 | 미량 |
정제수 | 잔량 |
계 | 100 |
원료명 | 함량 (중량%) |
제조예 16 | 5.0 |
알킬에텔당산염 (30%) | 30.0 |
알킬에텔설포석신산염 (30%) | 20.0 |
알킬아미도베타인 (30%) | 5.0 |
프로필렌글리콜 | 5.0 |
베타인 | 5.0 |
라우라미드디이에이 | 4.0 |
셀룰로스검 | 0.05 |
가수분해단백질 | 0.1 |
구연산 | 미량 |
NaCl | 미량 |
향 | 미량 |
방부제 | 미량 |
정제수 | 잔량 |
계 | 100 |
Claims (2)
- 목단피 추출물이 함유되는 화장료 조성물 중에,상기 목단피 추출물은 물, 알콜계 및 글리콜계를 포함하는 혼합 추출용매로부터 추출되고,상기 알콜계는 메탄올, 에탄올, 프로판올 및 부탄올로 이루어진 군중에서 선택되는 하나 이상이고,상기 글리콜계는 에틸렌글리콜, 프로필렌글리콜 및 부틸렌글리콜로부터 선택된 하나 이상이고,상기 물, 알콜계 및 글리콜계는 2: 1: 1의 중량비로 혼합되어 목단피로부터 인중합체를 수득할 수 있도록 하며,상기 목단피 추출물은 10.0~17.4 ng/ml 농도의 인중합체가 함유되는 것을 특징으로 하는 목단피 추출물을 함유하는 화장료 조성물의 제조방법.
- 제 1 항에 있어서, 상기 목단피 추출물은 목단피의 중량 10 내지 30배의 양으로 상기 혼합 추출용매를 가한 후, 50~100℃의 온도에서 5~20시간 동안 추출하여 얻어진 것을 특징으로 하는 목단피 추출물을 함유하는 화장료 조성물의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080109485A KR100882744B1 (ko) | 2008-11-05 | 2008-11-05 | 목단피 추출물을 함유하는 화장료 조성물의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080109485A KR100882744B1 (ko) | 2008-11-05 | 2008-11-05 | 목단피 추출물을 함유하는 화장료 조성물의 제조방법 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070044336A Division KR20080098925A (ko) | 2007-05-08 | 2007-05-08 | 목단피 추출물을 함유하는 화장료 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080108065A KR20080108065A (ko) | 2008-12-11 |
KR100882744B1 true KR100882744B1 (ko) | 2009-02-23 |
Family
ID=40368107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080109485A KR100882744B1 (ko) | 2008-11-05 | 2008-11-05 | 목단피 추출물을 함유하는 화장료 조성물의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100882744B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210060801A (ko) | 2019-11-19 | 2021-05-27 | 주식회사 사임당화장품 | 식물 복합 발효물을 유효성분으로 포함하는 항노화 화장료 조성물 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101990003B1 (ko) * | 2017-07-31 | 2019-06-17 | 주식회사 솔레온 | 모란 혼합 추출물을 함유한 항산화 및 피부미백용 화장료 조성물의 제조방법 및 이를 포함하는 화장료 조성물 |
CN113499290B (zh) * | 2021-07-15 | 2022-06-17 | 广州环亚化妆品科技股份有限公司 | 一种具有舒缓、修护作用的组合物及其制备方法和应用 |
CN113855599B (zh) * | 2021-10-28 | 2023-06-23 | 济南泽润生物科技有限公司 | 一种美白抗炎的牡丹提取物及其制备方法和在化妆品中的应用 |
CN118557473B (zh) * | 2024-04-30 | 2024-12-13 | 广州梵之容化妆品有限公司 | 一种抗光老和抗皮肤衰老的组合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000067187A (ko) * | 1999-04-24 | 2000-11-15 | 김상회 | 목단피 추출물을 함유하는 화장료 |
KR20020050414A (ko) * | 2000-12-21 | 2002-06-27 | 조명재 | 목단피 추출물을 유효성분으로 함유하는 구취 억제용 구강 조성물 |
KR20030064059A (ko) * | 2002-01-25 | 2003-07-31 | 나드리화장품주식회사 | 목단피추출물과 자귀나무추출물을 함유하는 노화방지화장료 조성물 |
KR20030068040A (ko) * | 2002-01-26 | 2003-08-19 | (주)마이크로 사이언스 테크 | 목단피 추출물을 유효성분으로 포함하는 조성물 |
-
2008
- 2008-11-05 KR KR1020080109485A patent/KR100882744B1/ko not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000067187A (ko) * | 1999-04-24 | 2000-11-15 | 김상회 | 목단피 추출물을 함유하는 화장료 |
KR20020050414A (ko) * | 2000-12-21 | 2002-06-27 | 조명재 | 목단피 추출물을 유효성분으로 함유하는 구취 억제용 구강 조성물 |
KR20030064059A (ko) * | 2002-01-25 | 2003-07-31 | 나드리화장품주식회사 | 목단피추출물과 자귀나무추출물을 함유하는 노화방지화장료 조성물 |
KR20030068040A (ko) * | 2002-01-26 | 2003-08-19 | (주)마이크로 사이언스 테크 | 목단피 추출물을 유효성분으로 포함하는 조성물 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210060801A (ko) | 2019-11-19 | 2021-05-27 | 주식회사 사임당화장품 | 식물 복합 발효물을 유효성분으로 포함하는 항노화 화장료 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20080108065A (ko) | 2008-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100882744B1 (ko) | 목단피 추출물을 함유하는 화장료 조성물의 제조방법 | |
KR100874115B1 (ko) | 백리향 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR101853743B1 (ko) | 음나무 추출물을 함유하는 피부 외용제 조성물 | |
KR101233832B1 (ko) | 홍삼 또는 인삼 유래 진세노사이드 알이와 알에이치투 복합체를 함유하는 화장료 조성물 및 그 제조 방법 | |
KR101078888B1 (ko) | 조직배양한 에키네시아 부정근 추출물을 포함하는 화장료 조성물 및 이의 제조 방법 | |
KR100954695B1 (ko) | 미선나무 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR20080098925A (ko) | 목단피 추출물을 함유하는 화장료 조성물 | |
KR20180065166A (ko) | 바다수선화 추출물과 블루로터스 추출물을 유효성분으로 하는 피부 미백용 화장료 조성물 | |
KR102632084B1 (ko) | 오이풀 추출물을 유효성분으로 포함하는 항산화, 피부미백 및 피부주름 개선용 화장료 조성물 | |
KR20170076147A (ko) | 피부 개선용 조성물 | |
KR102226179B1 (ko) | 항노화 화장료 조성물 | |
KR100920896B1 (ko) | 블루로터스 및 테트라하이드로커큐민을 유효성분으로함유하는 피부 미백용 화장료 조성물 | |
KR20120036417A (ko) | 참다시마 추출물을 유효성분으로 함유하는 피부 미백용 화장료 조성물 | |
KR101909578B1 (ko) | 제주양지꽃 추출물을 함유하는 피부 외용제 조성물 | |
KR101843976B1 (ko) | 흑효모 발효 발아녹두 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR100538078B1 (ko) | 산삼 추출물 및 생약 추출물을 함유하는 피부 노화 방지용화장료 조성물 | |
KR102378103B1 (ko) | 노니 및 마카뿌리의 발효추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR102471009B1 (ko) | 왕자귀나무 추출물을 함유하는 피부미백 또는 주름개선용 화장료 조성물 | |
KR102168533B1 (ko) | 한약재 추출물을 포함하는 미백 또는 안색 개선용 화장료 조성물 | |
KR101317433B1 (ko) | 지구자, 길경, 밀싹 및 세이지 추출물을 함유하는 미백 화장용 조성물 | |
KR20030090188A (ko) | 락테이트 및 감초 추출물을 포함하는 피부 미백용 화장료조성물 | |
KR101996547B1 (ko) | 산하엽 추출물을 유효성분으로 하는 피부 미백용 화장료 조성물 | |
KR101987425B1 (ko) | 갯버들 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR100744947B1 (ko) | 천궁 추출물 및 프로테아제를 유효성분으로 함유하는 피부미백용 화장료 조성물 | |
KR20220008081A (ko) | 아토피 등 극건성 피부의 보습과 진정, 피부장벽강화 효과를 지니는 흰민들레 태좌 배양 추출물 함유 피부개선용 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
PA0107 | Divisional application |
Comment text: Divisional Application of Patent Patent event date: 20081105 Patent event code: PA01071R01D |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20090120 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20090203 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20090203 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |